Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DermaVir Patch in Children, Adolescents, and Young Adults With HIV-1 Infection on HAART
NCT00614640Phase 2Withdrawn
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Primary completion
- Nov 2013
- Modality
- Nanoparticles, DNA Therapeutics, Vaccines & Immunotherapeutics
01
Overview
A Phase 2 trial of DermaVir in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Status: withdrawn.
02
Drugs
DermaVir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00614640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00614640.